These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21557643)

  • 1. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves.
    Bloch O; Golde P; Dohmen PM; Posner S; Konertz W; Erdbrügger W
    Tissue Eng Part A; 2011 Oct; 17(19-20):2399-405. PubMed ID: 21557643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
    Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
    J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti alpha-gal immune response following porcine bioprosthesis implantation in children.
    Park CS; Park SS; Choi SY; Yoon SH; Kim WH; Kim YJ
    J Heart Valve Dis; 2010 Jan; 19(1):124-30. PubMed ID: 20329498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-Gal specific IgG immune response after implantation of bioprostheses.
    Mangold A; Szerafin T; Hoetzenecker K; Hacker S; Lichtenauer M; Niederpold T; Nickl S; Dworschak M; Blumer R; Auer J; Ankersmit HJ
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):191-5. PubMed ID: 19670109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves.
    Choi SY; Jeong HJ; Lim HG; Park SS; Kim SH; Kim YJ
    J Heart Valve Dis; 2012 May; 21(3):387-97. PubMed ID: 22808845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenoantigenicity of porcine decellularized valves.
    Helder MRK; Stoyles NJ; Tefft BJ; Hennessy RS; Hennessy RRC; Dyer R; Witt T; Simari RD; Lerman A
    J Cardiothorac Surg; 2017 Jul; 12(1):56. PubMed ID: 28716099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse.
    Lim HG; Choi SY; Yoon EJ; Kim SH; Kim YJ
    Tissue Eng Part A; 2013 Nov; 19(21-22):2339-48. PubMed ID: 23672462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue.
    Kim MS; Lim HG; Kim YJ
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):894-900. PubMed ID: 25994817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery.
    Konakci KZ; Bohle B; Blumer R; Hoetzenecker W; Roth G; Moser B; Boltz-Nitulescu G; Gorlitzer M; Klepetko W; Wolner E; Ankersmit HJ
    Eur J Clin Invest; 2005 Jan; 35(1):17-23. PubMed ID: 15638815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
    Lim HG; Kim GB; Jeong S; Kim YJ
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):104-13. PubMed ID: 25315752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts.
    Lee C; Ahn H; Kim SH; Choi SY; Kim YJ
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory responses of tissue-engineered xenografts in a clinical scenario.
    Mathapati S; Verma RS; Cherian KM; Guhathakurta S
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):360-5. PubMed ID: 21183503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults.
    Park CS; Oh SS; Kim YE; Choi SY; Lim HG; Ahn H; Kim YJ
    J Heart Valve Dis; 2013 Mar; 22(2):222-9. PubMed ID: 23798212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves.
    Naso F; Gandaglia A; Iop L; Spina M; Gerosa G
    Acta Biomater; 2011 Apr; 7(4):1728-34. PubMed ID: 21118731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcific degeneration of bioprosthetic aortic valves in patients receiving steroid therapy.
    Eishi K; Ishibashi-Ueda H; Nakano K; Kosakai Y; Sasako Y; Kobayashi J; Yutani C
    J Heart Valve Dis; 1996 Nov; 5(6):668-72. PubMed ID: 8953446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response to crosslinked tissue is reduced in decellularized xenogeneic and absent in decellularized allogeneic heart valves.
    Böer U; Schridde A; Anssar M; Klingenberg M; Sarikouch S; Dellmann A; Harringer W; Haverich A; Wilhelmi M
    Int J Artif Organs; 2015 Apr; 38(4):199-209. PubMed ID: 25907532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in xenoreactive immune response and patterns of calcification of porcine and bovine tissues in α-Gal knock-out and wild-type mouse implantation models.
    Kim MS; Jeong S; Lim HG; Kim YJ
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):392-9. PubMed ID: 25549993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability?
    Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Gal Inactivated Heart Valve Bioprostheses Exhibit an Anti-Calcification Propensity Similar to Knockout Tissues.
    Naso F; Stefanelli U; Buratto E; Lazzari G; Perota A; Galli C; Gandaglia A
    Tissue Eng Part A; 2017 Oct; 23(19-20):1181-1195. PubMed ID: 29053434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.